Penserini L, Cantoni B, Antonelli M. Modelling the impacts generated by reclaimed wastewater reuse in agriculture: From literature gaps to an integrated risk assessment in a One Health perspective.
JOURNAL OF ENVIRONMENTAL MANAGEMENT 2024;
371:122715. [PMID:
39522187 DOI:
10.1016/j.jenvman.2024.122715]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2024] [Revised: 09/10/2024] [Accepted: 09/28/2024] [Indexed: 11/16/2024]
Abstract
The reuse of reclaimed wastewater is increasingly recognized as a viable alternative water source for irrigation. Its application, whether direct or indirect, impacts several interconnected compartments, including groundwater, surface water, soil, crops, and humans. Reclaimed wastewater provides essential resources for crops, like water and nutrients. However, it also introduces pathogens, and contaminants of emerging concern (CECs), defined as chemicals that may pose risks to human health and ecosystems but are not yet fully regulated, such as pharmaceuticals and personal care products, among others. Additionally, reclaimed wastewater may contain antibiotic-resistant bacteria (ARBs) and disinfection by-products (DBPs), all of which present potential health and environmental risks. Therefore, regulatory bodies stress the need for preventive risk assessments to ensure safe reuse. This paper critically reviews available models for assessing the impacts of reclaimed wastewater reuse in agriculture. It identifies gaps in current modelling approaches and outlines future research directions. Key areas requiring further investigation include the fate and transfer of CECs, ARBs and DBPs, and the co-occurrence of multiple risks in such interconnected systems, especially in the indirect reuse. To address these gaps, we proposed a simplified approach to integrate three types of risk associated with CECs in indirect reuse, focusing on risks posed by antibiotics and other pharmaceuticals: human health risk, environmental risk and risk from antibiotic resistance development. This approach aids in identifying the most critical endpoints within the One Health approach, supporting (i) CECs prioritization in regulations based on their critical endpoints and (ii) the adoption of CEC-specific mitigation measures.
Collapse